TY - JOUR
T1 - COVID-19 vaccine uptake and hesitancy opinions from frontline health care and social care workers
T2 - Survey data from 37 countries
AU - Chudasama, Radika V.
AU - Khunti, Kamlesh
AU - Ekezie, Winifred C.
AU - Pareek, Manish
AU - Zaccardi, Francesco
AU - Gillies, Clare L.
AU - Seidu, Samuel
AU - Davies, Melanie J.
AU - Chudasama, Yogini V.
PY - 2022/1
Y1 - 2022/1
N2 - Background and aims: Vaccine hesitancy is an ongoing major challenge. We aimed to assess the uptake and hesitancy of the COVID-19 vaccination. Methods: A short online survey was posted between April 12 to July 31, 2021 targeted at health and social care workers (HCWs) across the globe. Results: 275 from 37 countries responded. Most were hospital or primary care physicians or nurses, 59% women, aged 18–60 years, and 21% had chronic conditions with most prevalent being diabetes, hypertension, and asthma. We found that most HCWs (93%) had taken or willing to receive the COVID-19 vaccine. While 7% were vaccine hesitant (mainly women aged 30–39 years), respondents main concerns was the safety or potential side effects. Vaccine willing respondents raised concerns of unequal access to the COVID-19 vaccination in some countries, and highlighted that the only solution to overcoming COVID-19 infections was the vaccine booster doses given annually and free mass vaccination. Conclusions: This study found that the majority of the frontline HCWs are willing to receive the COVID-19 vaccine. Further promotion of the COVID-19 vaccine would reassure and persuade HCWs to become vaccinated.
AB - Background and aims: Vaccine hesitancy is an ongoing major challenge. We aimed to assess the uptake and hesitancy of the COVID-19 vaccination. Methods: A short online survey was posted between April 12 to July 31, 2021 targeted at health and social care workers (HCWs) across the globe. Results: 275 from 37 countries responded. Most were hospital or primary care physicians or nurses, 59% women, aged 18–60 years, and 21% had chronic conditions with most prevalent being diabetes, hypertension, and asthma. We found that most HCWs (93%) had taken or willing to receive the COVID-19 vaccine. While 7% were vaccine hesitant (mainly women aged 30–39 years), respondents main concerns was the safety or potential side effects. Vaccine willing respondents raised concerns of unequal access to the COVID-19 vaccination in some countries, and highlighted that the only solution to overcoming COVID-19 infections was the vaccine booster doses given annually and free mass vaccination. Conclusions: This study found that the majority of the frontline HCWs are willing to receive the COVID-19 vaccine. Further promotion of the COVID-19 vaccine would reassure and persuade HCWs to become vaccinated.
KW - Chronic disease
KW - COVID-19
KW - Hesitancy
KW - International
KW - Survey
KW - Vaccine
UR - http://www.scopus.com/inward/record.url?scp=85120916445&partnerID=8YFLogxK
UR - https://www.sciencedirect.com/science/article/pii/S1871402121003817?via%3Dihub
U2 - 10.1016/j.dsx.2021.102361
DO - 10.1016/j.dsx.2021.102361
M3 - Article
C2 - 34920206
AN - SCOPUS:85120916445
SN - 1871-4021
VL - 16
JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews
JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews
IS - 1
M1 - 102361
ER -